 |
   |
 |
  |
 |
 |
 |
 |
 |
|
|
||||||
|
|
||||||
|
|||||||
Am J Cardiol
Am J Cardiovasc Drugs
Am J Rhinol
Ann Clin Psychiatry
Arch Neurol
Arch Ophthalmol
BMC Research Notes
Br J Clin Pharmacol
Br J Urol International
Clin Drug Invest
Clin Pharmacol Ther
Clin Ther
Curr Med Res Opinion
Diabetes Care
Diabetes Obes Metab
Drugs of the Future
Drug Safety
Exp Opin Drug Metab Toxicol
Eur Heart J
Eur J Endocrinol
Eur Urol
Hung Med J
Int J Clin Pract
J Am Acad Child Adolesc Psychiatry
J Cardiovasc Pharmacol
J Sex Med
J Urol
Mayo Clin Proc
Nutr Metab Cardiovasc Dis
Value in Health
N-Acetylcysteine
Atypical antipsychotic
Bisphosphonates
Centrally acting skeletal muscle relaxant
HMG-CoA reductase inhibitors (statins)
Incretin enhancer (DPP-IV inhibitor)
Incretin mimetics
Insulin pen
Mammalian target of rapamycin (mTOR) inhibitor
MK-0524 (laropiprant)
Oral second-generation H1 antihistamine
Phosphodiesterase type 5 inhibitors
Selective norepinephrine reuptake inhibitor (for ADHD)
Selective serotonin/norepinephrine reuptake inhibitor
Topical second-generation H1 antihistamine